Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6023_Библиотеки_им_академика_М_И_Перельмана.pdf
Bibliography
43. Khan MA, Brady CJ, Kaiser RS.Clinical management of proliferative vitreoretinopathy: an
update [J]. Retina. 2015;35(2):165–75.
44. Wong D, Van Meurs JC, Stappler T, etal. A pilot study on the use of a peruorohexyloctane/
silicone oil solution as a heavier than water internal tamponade agent [J]. Br J Ophthalmol.
2005;89(6):662–5.
45. Heimann H, Stappler T, Wong D.Heavy tamponade 1: a review of indications, use, and complications [J]. Eye (Lond). 2008;22(10):1342–59.
46. Hsu YJ, Hsieh YT, Yeh PT, et al. Combined tractional and rhegmatogenous retinal
detachment in proliferative diabetic retinopathy in the anti-VEGF era [J]. J Ophthalmol.
2014;2014:917375.
47. Tao Y, Jiang YR, Li XX, et al. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment [J]. Retina.
2010;30(3):447–51.
48. Rahimy E, Pitcher JR, Gee CJ, etal. Diabetic tractional retinal detachment repair by vitreoretinal fellows in a county health system [J]. Retina. 2015;35(2):303–9.
49. Gandorfer A, Haritoglou C, Kampik A.Toxicity of indocyanine green in vitreoretinal surgery
[J]. Dev Ophthalmol. 2008;42:69–81.
50. Taniuchi S, Hirakata A, Itoh Y, etal. Vitrectomy with or without internal limiting membrane
peeling for each stage of myopic traction maculopathy [J]. Retina. 2013;33(10):2018–25.
51. Gass CA, Haritoglou C, Messmer EM, et al. Peripheral visual eld defects after macular hole surgery: a complication with decreasing incidence [J]. Br J Ophthalmol.
2001;85(5):549–51.
52. Imai H, Ohta K.Microperimetric determination of retinal sensitivity in areas of dissociated
optic nerve ber layer following internal limiting membrane peeling [J]. Jpn J Ophthalmol.
2010;54(5):435–40.
53. Lin KL, Hirose T, Kroll AJ, etal. Prospects for treatment of pediatric vitreoretinal diseases
with vascular endothelial growth factor inhibition [J]. Semin Ophthalmol. 2009;24(2):70–6.
54. Yu H, Li T, Luo Y, etal. Long-term outcomes of vitrectomy for progressive X-linked retinoschisis [J]. Am J Ophthalmol. 2012;154(2):394–402.
55. Trese MT.Enzymatic-assisted vitrectomy [J]. Eye (Lond). 2002;16(4):365–8.
56. Sharma T, Gopal L, Shanmugam MP, etal. Retinal detachment in Marfan syndrome: clinical
characteristics and surgical outcome [J]. Retina. 2002;22(4):423–8.
57. Kreissig I.Minimal surgery for retinal detachment. Thieme; 2000. ISBN 3131110619.
58. Heimann H, Bartz-Schmidt KU, et al. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study.
Ophthalmology. 2007;114(12):2142–54.
373